Back
ImmunityBio, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22
IBRX
ImmunityBio, Inc.
Last Price:
$2.09
Seasonality Move:
74.15%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and IBRX is experiencing slight buying pressure.
ImmunityBio, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.19 | Sell |
| 20-day SMA: | 2.2 | Sell |
| 50-day SMA: | 2.26 | Sell |
| 200-day SMA: | 2.56 | Sell |
| 8-day EMA: | 2.16 | Sell |
| 20-day EMA: | 2.18 | Sell |
| 50-day EMA: | 2 | Buy |
| 200-day EMA: | 0.99 | Buy |
ImmunityBio, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 43.81 | Sell |
| Chaikin Money Flow: | 5962040 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.27) | Sell |
| Bollinger Bands (100): | (2.17 - 2.57) | Sell |
ImmunityBio, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ImmunityBio, Inc. Stock
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 2.08 while IBRX 8-day simple moving average is 2.19, which is a Sell signal.
-
The stock price of IBRX is 2.08 while ImmunityBio, Inc. 20-day SMA is 2.20, which makes it a Sell.
-
ImmunityBio, Inc. 50-day simple moving average is 2.26 while IBRX share price is 2.08, making it a Sell technically.
-
IBRX stock price is 2.08 and ImmunityBio, Inc. 200-day simple moving average is 2.56, creating a Sell signal.
IBRX Technical Analysis vs Fundamental Analysis
Sell
22
ImmunityBio, Inc. (IBRX)
is a Sell
Is ImmunityBio, Inc. a Buy or a Sell?
-
ImmunityBio, Inc. stock is rated a SellThe current ImmunityBio, Inc. [IBRX] share price is $2.08. The Score for IBRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
ImmunityBio, Inc. Stock Info
Market Cap:
2B
Price in USD:
2.08
Share Volume:
41.7M
ImmunityBio, Inc. 52-Week Range
52-Week High:
4.27
52-Week Low:
1.83
Sell
22
ImmunityBio, Inc. (IBRX)
is a Sell
ImmunityBio, Inc. Share Price Forecast
-
What is the ImmunityBio, Inc. stock price today?The ImmunityBio, Inc. stock price is 2.08 USD today.
-
Will IBRX stock go up or go down?ImmunityBio, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is ImmunityBio, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ImmunityBio, Inc. is overvalued.
Is ImmunityBio, Inc. Stock a Buy?
-
ImmunityBio, Inc. share price is 2.08 while IBRX 8-day exponential moving average is 2.16, which is a Sell signal.
-
The stock price of IBRX is 2.08 while ImmunityBio, Inc. 20-day EMA is 2.18, which makes it a Sell.
-
ImmunityBio, Inc. 50-day exponential moving average is 2.00 while IBRX share price is 2.08, making it a Buy technically.
-
IBRX stock price is 2.08 and ImmunityBio, Inc. 200-day simple moving average is 0.99, creating a Buy signal.
Fundamental Analysis of ImmunityBio, Inc.
Is ImmunityBio, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.14 per share.
Technical Analysis of ImmunityBio, Inc.
Should I short ImmunityBio, Inc. stock?
-
IBRX Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting ImmunityBio, Inc. is a Buy
-
ImmunityBio, Inc. Relative Strength Index (RSI) is 43.81, which suggest ImmunityBio, Inc. is oversold
-
The Bollinger Bands (25) for ImmunityBio, Inc. is (2.07 - 2.27), which suggest ImmunityBio, Inc. is a Sell
-
The Bollinger Bands (100) for ImmunityBio, Inc. is (2.17 - 2.57), which suggest ImmunityBio, Inc. is a Sell
* ImmunityBio, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.